Position in TECH
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$989,665
+$337,043 QoQ
Shares Held
14,008
+12.2% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#284
of 588 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TECH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AZZAD ASSET MANAGEMENT INC /ADV holds $5,807,017 across 7 Biotechnology names. TECH ranks #3 (17.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,630 | $1,393,768 | |
| 2 | INCY |
Incyte Corp
|
9,067 | $1,027,835 | |
| 3 | TECH |
BIO-TECHNE Corp
This page
|
14,008 | $989,665 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
12,424 | $972,426 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
984 | $613,563 | |
| 6 | EXEL |
Exelixis, Inc.
|
7,911 | $430,437 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
4,784 | $379,323 |
All Filings in TECH
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $989,665 | 14,008 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $652,622 | 12,488 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $750,474 | 12,761 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $773,980 | 13,913 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,384,295 | 46,342 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,695,455 | 45,974 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $3,324,256 | 46,151 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $3,690,448 | 46,171 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $3,198,312 | 44,638 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $3,137,282 | 44,570 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $3,360,086 | 43,547 | Shares | Sole | 2024-04-01 | |
| 2023-09-30 | $2,638,393 | 38,760 | Shares | Sole | 2024-04-01 | |
| 2023-06-30 | $2,523,917 | 30,919 | Shares | Sole | 2024-04-01 | |
| 2023-03-31 | $2,066,043 | 27,848 | Shares | Sole | 2024-04-01 | |
| 2022-12-31 | $982,210 | 11,851 | Shares | Sole | 2024-04-01 | |
| 2022-09-30 | $2,703,396 | 9,519 | Shares | Sole | 2024-04-01 | |
| 2022-06-30 | $3,280,254 | 9,463 | Shares | Sole | 2024-04-01 | |
| 2022-03-31 | $2,645,874 | 6,110 | Shares | Sole | 2024-04-01 | |
| 2021-12-31 | $3,087,485 | 5,968 | Shares | Sole | 2024-04-01 | |
| 2021-09-30 | $3,119,661 | 6,438 | Shares | Sole | 2024-04-01 | |
| 2021-06-30 | $2,910,930 | 6,465 | Shares | Sole | 2024-04-01 | |
| 2021-03-31 | $2,721,633 | 7,126 | Shares | Sole | 2024-04-01 | |
| 2020-12-31 | $2,273,340 | 7,159 | Shares | Sole | 2024-04-01 | |
| 2020-09-30 | $1,271,845 | 5,134 | Shares | Sole | 2024-04-01 | |
| 2020-06-30 | $824,162 | 3,121 | Shares | Sole | 2024-04-01 | |
| 2020-03-31 | $547,432 | 2,887 | Shares | Sole | 2024-04-01 | |
| No filing history on record for this holder in this stock. | ||||||